Business

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

Published On : 2026-01-14

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related peptide (CGRP) antagonist treatment option for both pediatric and adult patients.1,2 Results from the SPACE trial found AJOVY significantly reduced monthly migraine days and monthly headache days versus placebo over a 12-week period in pediatric […]

#Business

Business

Asia Loan Bankers Brace for Competition, Thinner Margins in 2026

Published On : 2026-01-14

Loan bankers in Asia are bracing for an increasingly competitive market that is squeezing the returns they earn on lending, as they grapple with subdued syndicated deal flow.

#Business

Business

Enerflex Ltd. Announces Timing of Fourth Quarter Financial and Operational Results

Published On : 2026-01-14

CALGARY, Alberta, Jan. 14, 2026 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) plans to release its financial results and operating highlights for the year ended December 31, 2025, on Thursday, February 26, 2026 prior to market open. Results will be communicated by news release and will be available on […]

#Business

Business

Flurry of cannabis M&A that followed Trump marijuana rescheduling a sign of things to come

Published On : 2026-01-14

A flurry of cannabis business transactions came on the heels of President Donald Trump’s Dec. 18 executive order – with many more to come once marijuana rescheduling is finalized.Flurry of cannabis M&A that followed Trump marijuana rescheduling a sign of things to come is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

#Business

Discover more from Trend Teller

Subscribe to get the latest posts sent to your email.